Keywords: pfizer, selects, r343, rigel, earns, 5m, milestone

Pfizer selects R343, Rigel earns $5M milestone

Article | 22 May 2006

The USA's Rigel Pharmaceuticals says that R343, its novel small-molecule drug candidate, has been selected for advanced preclinical development in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing